PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

212.18B

Vuru Grade

72.21/100

Current Price

$34.62
+0.03 (+0.09%)

Growth Price

$28.95
Overvalued by 16.36%

Stability Price

$12.06
Overvalued by 65.15%

Company Metrics

  • 24.35 P/E
  • 4.27 P/S
  • 3.05 P/B
  • 1.42 EPS
  • 12.30% Cash ROIC
  • 1.67 Cash Ratio
  • 1.12 / 3.20 % Dividend
  • 29.17M Avg. Vol.
  • 6.13B Shares
  • 212.18B Market Cap.

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

What to Expect From Merck and Pfizer Earnings
24/7 Wall St. - 19 hours ago
Pharmaceutical giants Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) are both releasing their first quarter financial results Tuesday before the markets open.
Stocks to Watch: Apple, Ford, Merck - Wall Street Journal (blog)
Pfizer Trims Outlook on Stronger Dollar
Wall Street Journal - 3 hours ago
Pfizer has had to combat a wave of patent expirations weighing on sales, while a stronger dollar also has hurt results. The company has forged development partnerships and sought to make deals in a busy time for pharmaceutical mergers and acquisitions.
Pfizer Inc (PFE) Cuts 2015 Guidance, Q1 Earnings Exceed Forecasts - Bidness ETC
Pfizer Posts Upbeat Q1 Results, But Lowers FY Forecast - Benzinga
Pfizer Inc. (PFE) Rumored To Be Eyeing British Giant GlaxoSmithKline plc (ADR)
Bidness ETC - Apr 27, 2015
Pfizer Inc. (NYSE:PFE) went big exactly a year ago when it announced a takeover offer for UK-based AstraZeneca plc (ADR) (NYSE:AZN).
Pfizer Earns "AA-" Credit Rating from Morningstar (PFE) - sleekmoney
Pfizer (PFE) Set to Announce Earnings on Tuesday - Mideast Time
Whisper Numbers: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), And Bristol-Myers ...
Bidness ETC - 4 hours ago
Pharmaceutical companies Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), & Bristol-Myers Squibb Co (NYSE:BMY) are scheduled to report their earnings for the first quarter of fiscal year 2015 (1QFY15) before markets open today.
Merck (MRK), Pfizer (PFE), Bristol-Myers Squibb (BMY) – Drugmakers Report ... - LearnBonds
Cancer's Six-Figure Potential Blockbusters Lift Drugmaker Sales - Bloomberg
Swedish Rare Diseases Drug-Maker Sobi Soars On Takeover Bid; Pfizer Inc ...
Bidness ETC - 3 hours ago
Sobi manufactures and markets drugs for hemophilia, metabolic diseases, autoimmune diseases, and cancer. Significant treatments include arthritis drug Kineret and a rare metabolic disorder therapy Orfadin.
Swedish Orphan Said to Be Open to Sale Amid Boom in Drug Deals - Bloomberg
Pharmaceutical company Sobi said to be open to sale -Bloomberg - Reuters
Earnings Buzz: Apple Inc (AAPL), Twitter Inc (TWTR), LinkedIn Corp (LNKD ...
International Business Times - 19 hours ago
As Apple Inc. releases quarterly results after the closing bell on Monday, the earnings season gets into full swing this week. Social media company Twitter Inc. and drugmaker Pfizer Inc. report results Tuesday, followed by professional networking site ...
Twitter Inc, Nokia Corporation, Apple Inc. – Earnings This Week - ValueWalk
Take Profits In Pfizer Stock Ahead Of First-Quarter Earnings (PFE)
Seeking Alpha - Apr 27, 2015
It make more sense to lock in profits now and wait to hear what the company says about its business outlook for the rest of the year.
7 DJIA Earnings Previews for This Week: Apple, Merck, Pfizer, Exxon, Visa ... - 24/7 Wall St.
Pfizer Profit Tops Estimates as Prevnar Vaccine Sales Rise
Bloomberg - 3 hours ago
Pfizer Inc. reported first-quarter profit that exceeded analysts' estimates, boosted by better-than-projected sales of its Prevnar vaccines.
Pfizer Earnings: What The Street And The Crowd Expect
Benzinga - 21 hours ago
Pfizer Inc. (NYSE: PFE) will announce its first quarter financial results on Tuesday morning, before the market opens. According to Estimize, Wall Street analysts and the crowd pretty much agree regarding expectations.
What to look for in Pfizer earnings
MarketWatch - 16 hours ago
One of several big pharmaceutical companies to report Tuesday, Pfizer Inc. will be the subject of close scrutiny as investors to see how the drug-making giant is coping with a product line being depleted by expiring patents.
Pfizer Earnings Preview: Patent Cliff Still Looming - Investorplace.com